Published in Curr Opin Anaesthesiol on April 01, 2015
Massive hemorrhage management-a best evidence topic report. Ther Clin Risk Manag (2015) 0.77
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation. Crit Care (2016) 0.76
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg (2007) 5.32
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace (2013) 5.16
Incidence and predictors of severe obstetric morbidity: case-control study. BMJ (2001) 4.75
Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology (2005) 4.34
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol (2013) 4.04
Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65
Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia (2014) 3.32
Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury (2007) 3.04
Guidelines on oral anticoagulation (warfarin): third edition--2005 update. Br J Haematol (2006) 3.03
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation (2013) 3.02
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med (2013) 2.84
A specific antidote for dabigatran: functional and structural characterization. Blood (2013) 2.77
Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet (2010) 2.65
Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care (2007) 2.51
An update of consensus guidelines for warfarin reversal. Med J Aust (2013) 2.41
Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth (2012) 2.30
Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran. Stroke (2011) 2.20
Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology (2013) 2.08
Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost (2006) 1.94
Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery. Br J Anaesth (2013) 1.86
Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med (2006) 1.76
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost (2014) 1.74
Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion (2008) 1.73
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost (2006) 1.72
Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost (2010) 1.71
A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol (2000) 1.70
Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model. J Thromb Haemost (2012) 1.70
Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation (2013) 1.63
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood (2014) 1.61
Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg (2014) 1.61
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost (2012) 1.51
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model. Crit Care (2014) 1.49
FIBTEM provides early prediction of massive transfusion in trauma. Crit Care (2011) 1.48
The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg (2009) 1.43
Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury (2010) 1.36
Blood coagulation factor XIII: structure and function. Thromb Res (1999) 1.32
The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost (2007) 1.31
Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth (2010) 1.30
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol (2001) 1.17
Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost (2005) 1.08
Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. J Thorac Cardiovasc Surg (2013) 1.05
Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood (2014) 1.03
The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth (2010) 1.02
The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran. Int J Lab Hematol (2012) 1.01
Acute traumatic coagulopathy. Curr Opin Anaesthesiol (2012) 1.01
Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res (2011) 0.98
Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion (2013) 0.96
The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care (2013) 0.95
Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res (2002) 0.94
Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth (2011) 0.91
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury (2012) 0.91
Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury. J Trauma Acute Care Surg (2014) 0.88
Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding. J Thromb Haemost (2011) 0.87
The coagulopathy of cardiopulmonary bypass. Crit Rev Clin Lab Sci (2010) 0.83
Real-Time Live Confocal Fluorescence Microscopy as a New Tool for Assessing Platelet Vitality. Transfus Med Hemother (2010) 0.82
Fibrinogen depletion in trauma: early, easy to estimate and central to trauma-induced coagulopathy. Crit Care (2013) 0.80
Haemostatic changes in the puerperium '6 weeks postpartum' (HIP Study) - implication for maternal thromboembolism. BJOG (2009) 0.79
In reply. Transfusion (2013) 0.77
Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery. Thromb Res (2013) 0.77
Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model. Thromb Res (2014) 0.77
The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders. Hematology Am Soc Hematol Educ Program (2013) 0.76
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol (2013) 4.04
Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg (2007) 2.68
Societal costs of inappropriate emergency department thoracotomy. J Am Coll Surg (2011) 2.13
Traumatic abdominal wall hernia: epidemiology and clinical implications. J Trauma (2006) 1.70
Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion (2005) 1.45
Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Anesth Analg (2009) 1.44
Effects of fibrinogen concentrate after shock/resuscitation: a comparison between in vivo microvascular clot formation and thromboelastometry*. Crit Care Med (2013) 1.40
Biopsychronology: live confocal imaging of biopsies to assess organ function. Transpl Int (2014) 1.38
An approach to transfusion and hemorrhage in trauma: current perspectives on restrictive transfusion strategies. Can J Surg (2007) 1.32
Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood. Thromb Res (2005) 1.12
The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg (2002) 1.12
Austrian Moderate Altitude Study 2000 (AMAS 2000). The effects of moderate altitude (1,700 m) on cardiovascular and metabolic variables in patients with metabolic syndrome. Eur J Appl Physiol (2002) 1.09
Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy. Transfus Med Hemother (2012) 1.08
Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care (2014) 1.03
Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma (2011) 1.02
Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med (2013) 0.99
Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth Analg (2008) 0.96
Disseminated intravascular coagulopathy in the first 24 hours after trauma: the association between ISTH score and anatomopathologic evidence. J Trauma (2011) 0.95
Uncomplicated acute cholecystitis: early or delayed laparoscopic cholecystectomy? Rev Col Bras Cir (2012) 0.95
TEG® and ROTEM® in trauma: similar test but different results? World J Emerg Surg (2012) 0.95
Coagulation changes and edema formation during long-distance bus travel. Blood Coagul Fibrinolysis (2004) 0.94
The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg (2008) 0.92
Fibrinogen in craniosynostosis surgery. Anesth Analg (2008) 0.91
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury (2012) 0.91
Tranexamic acid for traumatic hemorrhage. Rev Col Bras Cir (2012) 0.90
Formation of edema and fluid shifts during a long-haul flight. J Travel Med (2003) 0.90
Recombinant activated coagulation factor VII and bleeding trauma patients. J Trauma (2006) 0.89
Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg (2003) 0.89
Microcirculatory parameters after isotonic and hypertonic colloidal fluid resuscitation in acute hemorrhagic shock. J Trauma (2009) 0.88
The utility of recombinant factor VIIa as a last resort in trauma. World J Emerg Surg (2012) 0.85
Fibrinogen concentrate in dilutional coagulopathy: a dose study in pigs. Transfusion (2013) 0.84
Operating room use of hypertonic solutions: a clinical review. Clinics (Sao Paulo) (2008) 0.84
Blood coagulation activation and fibrinolysis during a downhill marathon run. Blood Coagul Fibrinolysis (2007) 0.84
An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesth Analg (2009) 0.83
Nonoperative management for patients with grade IV blunt hepatic trauma. World J Emerg Surg (2012) 0.83
Changes in blood coagulation of arm and leg veins during a simulated long-haul flight. Thromb Res (2006) 0.83
Changes of biochemical markers and functional tests for clot formation during long-haul flights. Thromb Res (2002) 0.81
Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation. Anesth Analg (2005) 0.81
Successful reversal of deleterious coagulopathy by recombinant factor VIIa. Anesth Analg (2005) 0.80
Sequential closure of the abdominal wall with continuous fascia traction (using mesh or suture) and negative pressure therapy. Rev Col Bras Cir (2013) 0.79
Austrian Moderate Altitude Study (AMAS 2000) - fluid shifts, erythropoiesis, and angiogenesis in patients with metabolic syndrome at moderate altitude (congruent with 1700 m). Eur J Appl Physiol (2002) 0.79
Evidence-based telemedicine: trauma & acute care surgery (EBT-TACS). Rev Col Bras Cir (2012) 0.79
Hepatic trauma: a 21-year experience. Rev Col Bras Cir (2013) 0.78
Recombinant human prothrombin reduced blood loss in a porcine model of dilutional coagulopathy with uncontrolled bleeding. Blood Coagul Fibrinolysis (2017) 0.78
Austrian Moderate Altitude Study (AMAS 2000): erythropoietic activity and Hb-O(2) affinity during a 3-week hiking holiday at moderate altitude in persons with metabolic syndrome. High Alt Med Biol (2005) 0.78
Editorial: "formula-driven" versus "lab-driven" massive transfusion protocols: at a state of clinical equipoise. Transfus Med Rev (2009) 0.77
Air travel, hypobaric hypoxia, and prothrombotic changes. JAMA (2006) 0.76
Injectable hemostatic adjuncts in trauma: Fibrinogen and the FIinTIC study. J Trauma Acute Care Surg (2015) 0.76
Vacation at moderate and low altitude improves perceived health in individuals with metabolic syndrome. J Travel Med (2004) 0.76
Antiplatelet and anticoagulant prophylaxis and postoperative blood loss in cardiac surgery. Anesth Analg (2004) 0.75
The lost (to follow-up) intervention. Transfusion (2011) 0.75
Just another fascinating property of hypertonic solutions or something clinically relevant this time? Crit Care Med (2012) 0.75
Acquired von Willebrand syndrome in cardiac patients. J Cardiothorac Vasc Anesth (2007) 0.75
Massive transfusion strategy or massive confusion in trauma with massive and ongoing bleeding. Resuscitation (2011) 0.75
Colloidophobia. Minerva Anestesiol (2016) 0.75
Selective nonoperative management of high grade splenic trauma. Rev Col Bras Cir (2013) 0.75
The use of corticosteroid for the prophylaxis of fat embolism syndrome in patients with long bone fracture. Rev Col Bras Cir (2014) 0.75
Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy. Clin Appl Thromb Hemost (2007) 0.75
Therapeutic Plasma Transfusion in Bleeding Patients: A Systematic Review. Anesth Analg (2017) 0.75
Leg edema formation and venous blood flow velocity during a simulated long-haul flight. Thromb Res (2007) 0.75
[Management of retained hemothoraces after chest tube thoracostomy for trauma]. Rev Col Bras Cir (2012) 0.75
Management of hemorrhage in patients with pelvic fracture and hemodynamically unstable. Rev Col Bras Cir (2012) 0.75
Venous thromboembolism prophylaxis in patients with traumatic brain injury. Rev Col Bras Cir (2012) 0.75
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol (2017) 0.75
[Coagulation factor XIII – Pathophysiology, clinic and therapy of factor XIII deficiency]. Anasthesiol Intensivmed Notfallmed Schmerzther (2015) 0.75
Not complicated acute appendicitis in adults: clinical or surgical treatment? Rev Col Bras Cir (2012) 0.75